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Abstract
Background: Binostril endoscopic transsphenoidal approach (BETA) provides sufficient manipulation space and
wide endoscopic vision, although it increases the trauma of nose. Mononostril endoscopic transsphenoidal
approach (META) has minimal trauma of nose, at the expense of space within the operation. We describe a one-
and-a-half nostril endoscopic transsphenoidal approach (OETA) that combines the advantages of BETA and
META.
Methods: We introduced OETA for pituitary adenomas with a detailed technical description. A retrospective analysis
was also performed on 57 consecutive patients who underwent one-and-a-half nostril endoscopic transsphenoidal
surgery between March 2014 and June 2015 at Jinling hospital.
Results: The gross total resection rate was 79%. The gross complete resection rate of Knosp grade 3 tumors were 63.6,
and 27.3% in grade 4 tumors. Postoperative hormone remission was achieved in 14 out of 18 (77.8%) patients
with secreting adenomas. Postoperative abnormal visual function improvement was achieved in 23 out of 32
patients (73%) with preoperative visual dysfunction. The overall intra-operative CSF leak was 17.5%, with the
postoperative CSF leak decreased to 3.5% after the sellar reconstruction with the unilateral “rescue” nasoseptal
flap procedure. The main sinonasal complaints 2 weeks after surgery were: loss of sense of smell (28%), decrease in
sense of taste (4%), trouble breathing during the day (18%), thick nasal discharge (36%), post nasal discharge (8%),
dried nasal material (6%), and headache (6%). Three months after surgery, there were no reports of decrease of taste,
post nasal discharge, or dried nasal material. Other complaints were decreased significantly. Six months after surgery,
the main complaints of sinonasal quality of life were negligible, and overall health status was near complete recovery
to preoperative status.
Conclusions: The one-and-a-half nostril endoscopic transsphenoidal approach for pituitary adenomas is a simple and
reliable technique. It provides not only a sufficient surgical corridor for a 2-surgeon/4 or 3-hands technique, but also
ensures minimal invasion of the nasal canal.
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Background
Over the past several decades, the endonasalendoscopic
transsphenoidal approach (ETSS) has gradually become
the preferred surgical option for most pituitary adenomas
[1, 2]. This approach offers improved illumination and
superior panoramic visualization of the sella and the
surrounding structures [3–5]. Compared with traditional
sublabial or transseptal microscopic approach, ETSS offers
minimal invasiveness, fewer complications, and overall
improved outcomes [6, 7]. Traditionally, there are two
approaches to endoscopic transsphenoidal surgery for
pituitary adenomas: the two nostrils (binostril) approach
and the one nostril (mononostril) approach [8, 9]. Both of
the approaches have positives and negatives associated
with them.
The binostril approach with a 2-surgeon/4- or 3-hands
technique can provide a sufficient manipulation space
and a wider endoscopic vision, which helps to avoid
interference between instruments [10]. To create the
surgical corridor successfully, the surgeon dissects both
nasal cavities and resects parts of the posterior nasal
septum. Obviously, there are increased risks of rhinolo-
gical complications and postoperative discomfort. Recent
studies have shown that BETA presents poor early-
postoperative sinonasal QOL and a significant olfactory
alteration [6, 11, 12]. Many cases reported better results
using the mononostril approach [13, 14]. This technique
spares one nostril from dissection, thus avoiding large
resection and tissue manipulation. However, in the mono-
nostril approach, surgical freedom is more restricted by
the crowded nasal corridor and there are conflicts be-
tween the endoscope and dissecting instruments. More-
over, the presence of the nasal septum medially and the
prominences of the nasal turbinates prevent surgical
instruments from being angled toward the ipsilateral para-
sellar region [15].
In this technical report, we describe a one-and-a-half
nostril endoscopic transsphenoidal approach (OETA)
that combines the advantages of BETA and META. This
approach maintains sufficient surgical freedom and re-
tains the benefits of a 2-surgeon/4- or 3-hands tech-
nique, while preserving as much nasal septal mucosa as
possible. Likewise, it possesses minimal nasal invasive-
ness similar to the mononstril approach.
Methods
We retrospectively reviewed all patients that underwent
the one-and-a-half nostril endoscopic transsphenoidal
pituitary adenoma surgery at Jinling hospital, performed
by a senior neurosurgeon (CY M) from March 2014 to
June 2015. The medical records were reviewed for patient
demographics, tumor characteristics, surgical outcomes,
complications, and postoperative follow-up. The surgical
technique of the OETA is described below.
Surgical technique
The patient’s head was angled 20°–30° towards the left
shoulder, using a horseshoe head-holder, while under
general anesthesia and endotracheal intubation. The
surgeon worked on the right side of the patient and rou-
tinely used the right nasal cavity as a pathway for a 30°
endoscope (Karl Storz, Tuttlingen, Germany). The bilateral
nasal cavities were packed with cottonoids containing 1%
lidocaine for several minutes. No nasal speculum was used.
The right inferior and middle turbinates were out-fractured
bilaterally, which enabled a sufficiently large approach to
the sphenoethmoidal recess. After advancing an endoscope
over the right middle turbinate, the sphenoidostium was
observed at posterosuperior medial to superior turbinate
(Fig. 3a).
Then, the right “rescue” nasoseptal flap was created
with unipolar electrocautery (Fig. 1a). An anterior verti-
cal incision was performed along the perpendicular plate
of the ethmoid and posterior nasal septum, from 2 to
3 mm below the sphenoid ostium to the intercutaneo-
mucous point of the nasal vestibule. To preserve the
olfactory epithelium, the superior incision to the sphen-
oid ostium must be 1 to 2 cm below the most superior
aspect of the septum (Fig. 3b–d). The unilateral “rescue”
nasoseptal flap was gently reflected forward submuco-
sally and folded into the floor of nasal cavity outside of
the operative field of vision (Fig. 3e). If this nasoseptal
flap was necessary for sellar floor reconstruction at the
time of closure, a second incision was made along the
floor of the nasal cavity from the choanae to the front of
the first incision.
The next operation was to resect the bony nasal septum
using a dissector. The vomer was fractured across at the
base, and typically removed in one piece so as to preserve
the bone for sellar floor reconstruction. The resecting was
continued posteriorly until the sphenoid rostrum was
visible. The left nasal septum mucosa was then pushed
towards left cavity to make the left sphenoid ostium
visible.
The last step was to incise the left nasal septal mucosa
(Fig. 1b). The endoscope was introduced into the left
nostril, and the left inferior and middle turbinates were
out-fractured bilaterally. A vertical incision of the left
nasal septal mucosa was made with unipolar electro-
cautery, which extended approximately 2 cm at the
anterior-level of the middle turbinate (Fig. 3f ). These
procedures provided a sufficient binasal access for two
surgeons using the four-handed technique (Fig. 3g). At
the tumor resecting and sellar floor reconstruction stage,
the assistant surgeon guided the endoscope through the
right nostril while the senior surgeon manipulated the
instruments through both nostrils (Fig. 2c).
For most pituitary tumors, the unilateral “rescue”
nasoseptal flap was not necessary. The binasal mucosa
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Fig. 1 Illustration of the one-and-a-half nostril endoscopic transsphenoidal approach. a Creating the right “rescue” nasoseptal flap. The blue line
shows mucosal cutting line: from 2 to 3 mm below the sphenoid ostium to the intercutaneomucous point of the nasal vestibule. If anasoseptal
flap is necessary, the yellow mucosal cutting line is made: along the floor of the nasal cavity from the choanae to the front of the first incision. b
One-and-a-half approach: a vertical incision of the left nasal septal mucosa was made, which extended approximately 2 cm at the anterior-level
of the middle turbinate. Binostril approach: a part of left posterior septal mucosa was necessarily resected
Fig. 2 The difference between mononostril, one-and-a-half nostril and binostril approach. a Mononostril: a part of unilateral posterior septal mucosa
was need incision and the contralateral mucosa was integral maintained; all surgical instruments manipulation only in a nasal cavitie. b One-and-a-half
approach:the unilateral septal mucosa was required incising for a “rescue” nasoseptal flap, and the contralateral mucosa just needed approximately
2 cm incision; c Binostril approach: a part of bilateral posterior septal mucosa was necessarily resected. For one-and-a-half nostril and binostril approach,
the assistant surgeon guided the endoscope through the right nostril while the senior surgeon manipulated the instruments through both nostrils
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and turbinates were placed back in normal anatomic
position (Fig. 3h, i). If intraoperative cerebrospinal fluid
(CSF) leakage had occurred, the unilateral “rescue” naso-
septal flap was then fashioned to ensure a vascularized
repair. Nasal packing was performed for 24 h to prevent
postoperative mucosal adhesion.
The difference between META, BETA and OETA
The main difference was that the three approaches
followed different methods for resecting the nasal septum
mucosa. For the mononostril approach, a part of the
unilateral posterior septal mucosa was need incised, the
contralateral mucosa was integrally retained. All surgical
instruments were manipulated only in one nasal cavity
(Fig. 2a). For the binostril approach, a part of bilateral
posterior septal mucosa was necessarily resected (Fig. 2b).
For the one-and-a-half nostril approach, the unilateral
septal mucosa required incising from 2 to 3 mm below
the sphenoid ostium to the intercutaneomucous point of
the nasal vestibule, and the contralateral mucosa only
needed approximately 2 cm incision (Fig. 2c). Because the
contralateral septal olfactory strip and the vascular pedi-
cles of sphenopalatine were completely preserved, the risk
of epistaxis and anosmia theoretically were decreased. For
the one-and-a-half nostril and binostril approach, the
assistant surgeon guided the endoscope through the right
nostril while the senior surgeon manipulated the instru-
ments through both nostrils.
Results
Patient demographics and tumor characteristics
Fifty-seven consecutive patients were included for ana-
lysis (35 men, 22 women). The mean age was 49.7 years
(SD, 14.1 years; range, 18–83 years). The primary pre-
senting symptoms were abnormal visual functions (56%),
including vision loss and/or field-of-vision defect,
followed by endocrinopathy (32%) and headache (23%).
Twelve percent of adenomas were initially detected by
cranial imaging for other symptoms, and eleven percent
presented with pituitary apoplexy.
The mean volumes of the tumor were 22 × 20 ×
20 mm3, and seven cases were recurrent. According to
Fig. 3 Intraoperative endoscopic images. a Localisation of the sphenoid ostium at the sphenoethmoidalrecessus. b–d Creating the right “rescue”
nasoseptal flap- from 2 to 3 mm below the sphenoid ostium to the intercutaneomucous point of the nasal vestibule. e The nasoseptal flap was
gently folded in the floor of nasal cavity. f A vertical incision of the left nasal septal mucosa was made. g A sufficient binasal access for two-surgeons
using the four-handed technique. h–i The binasal mucosa and turbinates were placed back in normal anatomic position. a = sphenoid sinus ostium;
b = medial nasal septum; c = the bony nasal septum; d = the right middle nansal turbinate; e = the intercutaneomucous point of the nasal
vestibule; f = the vertical incision of the left nasal septal mucosa; g = the left middle nansal turbinate; h = the sphenoid rostrum
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the Knosp scale [16], most tumors presented as Knosp
grade 3 (33.3%), followed by Knosp grade 2 (28.1%) and
grade 4 (19.3%). The fewest were grade 0 (5.3%) and
grade 1 (14.0%). In 39 patients (68.4%), the tumor was
non-secreting. The most prevalent secreting tumor was
the producer of GH, in 12 patients (21.1%), followed by
prolactinoma, in four patients (7.0%), and adrenocortico-
tropic hormone (ACTH), in two patients (3.5%). This
data is in Table 1.
Surgical outcomes
Gross tumor resection (GTR) was determined by the ab-
sence of residual tumor on postoperative MRI. Postopera-
tive imaging showed total gross removal in 45 (79%)
patients. The gross total resection of patients was achieved
in 100% of tumors of Knosp grade 0 to 2, 63.6% of grade 3,
and 27.3% of grade 4.
Postoperative hormone evaluation showed that remis-
sion was achieved in 14 (77.8%) patients with secreting
adenomas. Remission was achieved in 10 (83.3%)
patients with growth hormone adenomas, in 3 (75%) pa-
tients with prolactinomas, and in 1 (50%) patient with
ACTH adenomas. Postoperative neuro-ophthalmological
evaluation revealed that 23 (72%) patients with previous
vision loss and/or field vision defect were improved, with
9 (28%) unchanged (Table 2).
Complications
Complications are listed in Table 3. An intra-operative
CSF leak was noted in 10 cases (17.5%), and all cases
were reconstructed with a unilateral “rescue” nasoseptal
flap. Two of these continued to leak post-operatively
and were recovered 1 week after lumbar drainage. The
seller dura of two cases were seriously injured during
operation, but not broken. These two cases were also
later reconstructed with a unilateral “rescue” nasoseptal
flap. No postoperative CSF leak occurred in these two
cases.
Other postoperative complications included temporary
diabetes insipidus in three cases (5.3%), and anterior
pituitary insufficiency in three cases (5.3%). There were
no instances of postoperative arterial epistaxis or
severe complications in the total cohort of 57 patients
(Table 3).
Postoperative follow-up
Seven cases were lost during follow-up and the mean
follow-up time was 18 months (range 6 to 24). To inves-
tigate patients’ sinonasal complaints and health status,
we conducted two questionnaires (Tables 4 and 5).
Table 1 Patient demographics and tumor characteristics
Patient age, mean ± SD, y 49.7 ± 14.1
Male/female, n 35/22
Follow up (range), mo 18 (6–24)
Tumor with volumes mm3 22*20*20
Recurrent, n (%) 7 (12.3%)
Presenting symptoms, n (%)




Pituitary apoplexy 6 (11%)






Nonfunctioning adenoma, n (%) 39 (68.4%)
Functioning adenoma, n (%) 18 (31.6%)
Growth hormone 12 (21.1%)
Prolactinomas 4 (7.0%)
ACTH 2 (3.5%)
Table 2 Outcomes of surgery








Hormonal remission rate, n (%)
Overall 14 (77.8%)
Growth hormone 10 (83.3%)
Prolactinomas 3 (75%)
ACTH 1 (50%)





Intraoperative cerebrospinal fluid leak 10 (17.5%)
The use of unilateral “rescue” nasoseptal flap 12 (21.1%)
Postoperative cerebrospinal fluid leak 2 (3.5%)
Temporary diabetes insipidus 3 (5.3%)
Anterior pituitary insufficiency 3 (5.3%)
Epistaxis 0
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The main sinonasal complaints 2 weeks after surgery
were: sense of smell damage (28%), sense of taste
damage (4%), trouble breathing during the day (18%),
thick nasal discharge (36%), post nasal discharge (8%),
dried nasal material (6%), and headache (6%). Three
months after surgery, there was no loss of sense of taste,
postnasal discharge, and dried nasal material reported.
Other complaints were decreased evidently: loss of sense
of taste reduced to 4%, the rate of trouble breathing dur-
ing the day decreased to 18%, the rate of thick nasal
discharge decreased to 36%, and the rate of headache
decreased to 2%. Six months after surgery, the main
sinonasal complaints had nearly all returned to pre-
operative levels or better. One 72 years old patient did
complain of trouble breathing during the day. The rea-
son he complained of trouble breathing was nasal syne-
chia. Through a simple operation of severing the nasal
adhesion under endoscope, his nasal trouble was cured
by an ENT doctor 9 months after surgery.
For health status, no patients reported being fully
healed within 2 weeks after surgery. Fifteen patients
(30%) recovered to preoperative status 3 months after
surgery, and 48 (96%) patients recovered to preoperative
status 6 months after surgery. Two patients with Knosp
grade 4 tumors had radiation therapy after their surgery,
and they recovered to normal status after 1 year post-
operation (Table 6).
Postoperative endoscopic visualization examination of
nasal cavity was performed to collect information on 20
outpatients 3 months after surgery. The results demon-
strated that the nasal mucosa was favorable to recovery
and a positive prognosis (Fig. 4).
Discussion
The two most commonly used endoscopic approaches
for pituitary adenomas are the binostril and mononostril
transsphenoidal approaches. Surgical outcomes, maneu-
verability of instruments, postoperative morbidity, and
postoperative quality of life are the four most important
principles that evaluate the efficiency of these two
approaches. For general pituitary adenomas, some recent
literature reported that the two approaches had similar
results in terms of gross tumor resection rate, hormonal
remission rate, improvement in visual function, CSF
leak, and inception of diabetes insipidus [17, 18]. How-
ever, the binostril approach is superior in terms of surgi-
cal freedom and the resecting of invasive pituitary
macroadenomas (such as tumors with parasellar and
suprasellar expansion, and tumors requiring extended
approaches) [19, 20]. There is additional damage to the
nasal cavity that accompanies the binostril approach.
Sinonasal complications, early postoperative sinonasal
quality of life, and olfactory changes present significant
negative impacts to the patient’s satisfaction with binos-
tril transsphenoidal surgery. The methods limiting the
sinonasal trauma of binostril approach are always of
significance within our clinical work. We have created a
one-and-a-half nostril endoscopic transsphenoidal ap-
proach, and this approach has proved highly effective
through practice.
The advantages of one-and-a-half nostril approach
Minimal invasiveness of nose: comparing OETA with BETA
In our opinions, OETA had less invasiveness to the nose,
with the following advantages. First, BETA needed resecting
of a part of the bilateral posterior septal mucosa, while
OETA preserved a mostly intact left nasal septal mucosa.
In the surgical procedure, the left nasal septal mucosa was
only dissected approximately 2 cm. This vertical incision
provided sufficient bi-nasal access and significantly reduced
the invasion of the nasal septal mucosa. Second, for OETA,
the right “rescue” nasoseptal flap preserved both the vascu-
lar pedicles of sphenopalatine or posterior nasal artery, as
well as the septal olfactory strip. We made efforts to
preserve the unilateral “rescue” nasoseptal flap. If intraoper-
ative cerebrospinal fluid leakage had not occurred, the
preserved unilateral “rescue” nasoseptal flap was success-
fully placed back in the normal anatomic position. Thus,
theoretically, the risk of epistaxis and anosmia were also
significantly decreased. For BETA, a part of the bilateral
posterior septal mucosa was displaced, with the possibility
of injury to the vascular pedicles of sphenopalatine and the
septal olfactory strip. As a consequence, BETA may in-
crease the risk of epistaxis and anosmia. In our series, there
was no epistaxis, and no permanent anosmia. In 96 % of
the patients the sense of smell returned to a normal level 3
months after operation. Moreover, 6 months after surgery,
the main sinonasal complaints were nearly completely
resolved. When comparing the epistaxis and permanent
anosmia rates in our OETA series to the literature-reported
BETA series, the former group seems to achieve better
preservation of the normal anatomy and physiology of the
nasal cavity.
In our series, in 96% of the patients the sense of smell
returned to a normal level 3 months after operation.
Moreover, 6 months after surgery, the main complaints
of sinonasal quality of life were nearly completely
Table 4 The main sinonasal complaints’ questionnaire
Question 1: What are your main sinonasal complaints?
Question 2: How do you feel about your sinonasal complaints?
A. Worse than preoperation B. Like preoperation
Table 5 The health status questionnaire
How do you feel about your health status?
A. Worse than preoperation B. Like preoperation
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resolved. In theory, for BETA, due to needing more
extensive coagulation of the mucosa, the postoperative
nasal cavity might require more time to restore to sound
health. In the future, we will conduct a prospective case-
control study to compare the sinonasal quality of life
and health status between OETA and BETA.
Maneuverability of instruments: comparing OETA with
META
Our surgical outcomes were equivalent to or superior
to those reported in the literature for endoscope based
series [1, 3, 4, 7–9], including 79% gross tumor resec-
tion rate, 77.8% hormonal remission rate, and 72% im-
provement in visual function. In our opinion, this
outcome may be attributable to the wide panoramic
view of the endoscope, independent of both the width
and depth of the access, which is not affected by the
OETA. Importantly, compared to META, the OETA
technique enhances the maneuverability of instru-
ments because surgeons can obtain sufficient operating
space via manipulation in both nasal cavities. Thus, with
the assistant surgeon holding the endoscope, the primary
surgeon can comfortably operate two instruments for
bleeding control, tumor removal, and the reconstruction
of the sellar floor.
For META, because of the space limitation in one
crowded nasal corridor, the surgical freedom may be
more affected by the presence of the endoscope and
conflicts between the endoscope and dissecting instru-
ments can arise. Especially, for macroadenomas with
obvious parasellar invasion (Knosp grade 3 and 4),
META has difficulty providing a direct view of the ipsi-
lateral surgical target area using the ipsilateral nostril; it
was a more favorable direction for the instruments
coming from the opposite nostril. For OETA, changing
the endoscope to the contralateral nostril could get the
view of the ipsilateral surgical target area. In our series,
even for Knosp grade 3 and 4 tumors, the rates of
grossly complete resection were 63.6 and 27.3%,
respectively (Table 7).
Therefore, with satisfactory visualization, sufficient
operating space, and superior maneuverability of instru-
ments, the OETA achieved excellent outcomes for resec-
tion of almost all pituitary adenomas.
Table 6 Sinonasal quality of life and health status (follow up = 50)
Sinonasal complaints Two weeks after surgery Three months after surgery Six months after surgery
Sense of smell damage 14 (28%) 2 (4%) 0
Sense of taste damage 2 (4%) 0 0
Trouble breathing day 9 (18%) 1 (2%) 1 (2%)
Thick nasal discharge 18 (36%) 5 (10%) 0
Post nasal discharge 4 (8%) 0 0
Dried nasal material 3 (6%) 0 0
Headache 3 (6%) 1 (2%) 1 (2%)
No sinonasal discomfort 1 (2%) 41 (82%) 48 (96%)
Health status
Recovering to preoperative status 0 15 (30%) 48 (96%)
Fig. 4 Postoperative outpatient follow-up after 3 months after surgery demonstrating the nasal mucosa favorable recovery and well prognosis. a
the right nasal cavity, the arrow shows the right “rescue” nasoseptal flap interface. b the left nasal cavity, the arrow shows the interface of incision
of the left nasal septal mucosa nasal. c The bottom of the saddle mucosa healed completely
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The advantage of the unilateral “rescue” nasoseptal flap
With respect to postoperative morbidity, our results are
comparable to that of other published series [1, 3, 4, 7–9, 20]
in regards to factors such as postoperative CSF leakage
(3.5%), anterior pituitary insufficiency (5.3%), and temporary
diabetes insipidus (5.3%). In this study, the cases with the pi-
tuitary adenomas with Knosp grade 3 to 4 accounted for
52.6% of the total cases (30/57). In the surgical procedure of
these cases, we observed 10 cases with tearing of the arach-
noid membrane, which led to intraoperative CSF leak. We
performed sellar packing with the unilateral “rescue” naso-
septal flap for the reconstruction in these cases. Just two of
these cases developed into postoperative transient CSF leak-
age. The two cases were effectively treated with spinal CSF
drainage for several days. These results show that the unilat-
eral “rescue” nasoseptal flap had contributed to effective re-
duction of the incidence of postoperative CSF leak.
Many neurosurgeons have used bilateral nasoseptal
“rescue” flaps as reconstructive materials [21–23].
Although this technique was reliable and efficient, the
bilateral nasoseptal flap increased the degree of damage
to nasoseptal mucosa. In our clinical experience, and in
accordance with our results, the unilateral “rescue” naso-
septal flap was enough for most reconstruction. This will
reduce the degree of damage to nasoseptal mucosa, as
well as preserve the contralateral nasoseptal mucosa for
the next potential re-operation.
Conclusions
The one-and-a-half nostril endoscopic transsphenoidal
approach for pituitary adenomas is a simple, yet reliable
technique. It provides not only a sufficient surgical corri-
dor for a 2-surgeon/4- or 3-hands technique, but also
minimal invasion of the nose. Its clinical results with
respect to surgical outcome, maneuverability of instru-
ments, postoperative morbidity, and postoperative quality
of life support the theory that this is a highly efficient
technique.
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